Finally, to confirm that endothelial dysfunction was inherent to loss of GATA5, not secondary to hypertension, we treated Gata5-null mice and their controls with hydralazine, a widely used vascular smooth muscle cell relaxant. The gene discussed is GATA5; the disease is endothelial dysfunction.